BioHarvest Sciences Inc. (BHST)
NGM – Real vaqt narxi. Valyuta: USD
3.84
+0.15 (4.07%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
3.84
+0.15 (4.07%)
Yopilishda: May 12, 2026, 4:00 PM EDT
BioHarvest Sciences Inc. Isroil va Qo'shma Shtatlarda biotexnologiya kompaniyasi sifatida faoliyat yuritadi. Kompaniya ikkita segment orqali ishlaydi: Mahsulotlar va CDMO xizmatlari. Kompaniya faol moddalar yuqori konsentratsiyasiga ega o'simlik hujayralarini ishlab chiqarish uchun botanika sintezi platformasi texnologiyasini ishlab chiqadi. Kompaniya sog'liq va salomatlik uchun ilmiy asoslangan nutraceutical yechimlarni tadqiq qilish, ishlab chiqish, ishlab chiqarish, marketing qilish va sotish bilan shug'ullanadi, ular parhez qo'shimchalari, shuningdek, funktsional oziq-ovqat va ichimliklar sifatida ishlab chiqariladi va sotiladi, shuningdek, sog'liq, farmatsevtika va kosmeceutical yechimlarni ishlab chiqarish, marketing qilish va sotish bilan shug'ullanadi. Kompaniya shuningdek, shartnoma asosida ishlab chiqish va ishlab chiqarish operatsiyalari xizmatlarini taqdim etadi. Bundan tashqari, u qizil uzum sharobida mavjud bo'lgan polifenollarning matritsasini o'z ichiga olgan qizil uzum hujayrasi parhez qo'shimchasi VINIAni taklif etadi. Kompaniya Vankuver, Kanadada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ilana Belzer Ph.D. | Chief Operating Officer |
| Dr. Malkit Azachi Ph.D. | Vice President of Research & Development |
| Dr. Yoheved Hagay Ph.D. | Co-Founder, CTO & Member of Scientific Advisory Board |
| Dr. Zaki Rakib Ph.D. | Co-Founder, CEO, Executive Chairman & President |
| Jared Turner | Vice President of D2C Products Business Unit |
| Mr. David K. Ryan | VP of Investor Relations & Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | 6-K | bhsc_6k.htm |
| 2026-05-01 | 6-K | bhsc_6k.htm |
| 2026-04-29 | 6-K | bhsc_6k.htm |
| 2026-03-31 | 40-F | bhst-20251231_40f.htm |
| 2026-03-27 | 6-K | bhsc_6k.htm |
| 2026-03-17 | 6-K | bhsc_6k.htm |
| 2026-03-16 | 6-K | bhsc_6k.htm |
| 2026-03-05 | 6-K | bhsc_6k.htm |
| 2026-03-03 | 6-K | bhsc_6k.htm |
| 2026-01-07 | 6-K | bhsc_6k.htm |
| Ms. Bar Dichter | Chief Financial Officer |
| Ms. Michal Abargel Sapir | Vice President of Regulatory Affairs |